Sleep disorders and epilepsy: optimising sleep to improve seizure control

Internal Medicine · Neurology
Sleep and epilepsy are closely interconnected, with sleep disturbances potentially influencing seizure susceptibility, seizure frequency, and treatment outcomes. Sleep deprivation is a recognised seizure precipitant in individuals with epilepsy, while nocturnal seizures can disrupt sleep architecture, contribute to daytime sleepiness, and aggravate existing sleep disorders. A significant influence on epileptic activity is exerted by sleep, with facilitation being observed during non‐rapid eye movement (NREM) sleep and inhibition during rapid eye movement (REM) sleep.[1] Seizure occurrence and interictal epileptiform discharges (IEDs) can be influenced by sleep, while sleep architecture and quality can, conversely, be affected by epilepsy and seizures.[2]In addition, conditions such as obstructive sleep apnoea (OSA), insomnia, and circadian rhythm disturbances may complicate seizure management. These interactions create a bidirectional relationship in which poor sleep may worsen seizure control, while uncontrolled seizures may further impair sleep quality. Therefore, the identification and management of sleep disorders should be incorporated into comprehensive epilepsy care to improve seizure outcomes and quality of life.Understanding the relationship between sleep and epilepsySleep influences neuronal excitability and epileptiform activity through changes in cortical synchronisation and neurotransmitter activity. Non-rapid eye movement (NREM) sleep, particularly slow-wave sleep, is associated with increased neuronal synchronisation and can facilitate the activation and propagation of interictal epileptiform discharges. Conversely, rapid eye movement (REM) sleep is generally associated with reduced epileptiform activity because of its relatively desynchronised cortical activitySeizure occurrence also varies according to sleep-wake patterns and epilepsy syndrome. For example, sleep-related hypermotor epilepsy predominantly manifests during NREM sleep, whereas seizures in juvenile myoclonic epilepsy frequently occur shortly after awakening. Sleep deprivation, irregular sleep schedules, and nocturnal sleep fragmentation may further increase seizure susceptibilityCommon sleep disorders in individuals with epilepsySeveral sleep disorders are frequently encountered in individuals with epilepsy and may remain underdiagnosed.Sleep disorderClinical relevance in epilepsyObstructive sleep apnoeaRecurrent upper airway obstruction causes intermittent hypoxaemia, sleep fragmentation, and daytime sleepiness, potentially aggravating seizure control.InsomniaDifficulty initiating or maintaining sleep contributes to sleep deprivation and may increase seizure susceptibility.Circadian rhythm sleep-wake disordersIrregular sleep timing and misalignment of the sleep–wake cycle may disrupt seizure patterns and medication adherence.Restless legs syndromeUncomfortable leg sensations and an urge to move the legs can interfere with sleep initiation and continuity.Excessive daytime sleepinessMay result from nocturnal seizures, sleep disorders, or antiseizure medication-related adverse effects.ParasomniasAbnormal behaviours during sleep may resemble nocturnal seizures, complicating clinical diagnosis.Recognising and evaluating sleep disturbancesA structured sleep assessment should be considered during routine epilepsy consultations, particularly when breakthrough seizures, unexplained daytime fatigue, or poor quality of life are reported. Clinical evaluation should include sleep duration, bedtime routines, nocturnal awakenings, snoring, witnessed apnoeic episodes, and daytime sleepiness. Information regarding seizure timing, frequency, and potential sleep-related triggers should also be documentedValidated screening tools, such as the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and STOP-Bang questionnaire, may help identify individuals requiring further assessmentPolysomnography (PSG) is particularly useful when OSA, parasomnias, or other sleep-related breathing disorders are suspected. Video-EEG monitoring combined with PSG may be required to differentiate nocturnal seizures from parasomnias. Sleep-deprived EEG may also improve the detection of interictal epileptiform discharges when clinically indicatedStrategies to optimise sleep and improve seizure controlA comprehensive management strategy should address both epilepsy and coexisting sleep disturbances. The following interventions may be incorporated into routine clinical practice.Establishing consistent sleep habits: Sleep hygiene measures are essential for reducing sleep deprivation and maintaining circadian rhythm stability. Individuals should be encouraged to:Maintain consistent bedtime and waking schedules, including weekendsObtain adequate sleep, generally 7-9 hours nightly for adults, with age-appropriate requirements for children and adolescentsAvoid excessive caffeine, Nicotine, and alcohol, particularly during the eveningLimit screen exposure and stimulating activities before bedtimeMaintain a comfortable, quiet, and dark sleeping environmentAvoid irregular sleep schedules and prolonged daytime napsA sleep diary can help identify sleep-related seizure triggers and monitor improvements following behavioural interventions.Managing obstructive sleep apnoea: OSA should be actively investigated in individuals with epilepsy who experience habitual snoring, witnessed apnoeic episodes, morning headaches, or excessive daytime sleepiness. Continuous positive airway pressure (CPAP) is the standard treatment for appropriate patients, while weight management, positional therapy, and oral appliances may be considered according to clinical indicationsTreatment of OSA has been associated with improved seizure control, although evidence from randomised controlled trials remains limited. CPAP adherence should be assessed regularly to establish treatment effectivenessAddressing insomnia and other sleep disorders: Cognitive behavioural therapy for insomnia (CBT-I) is considered a first-line intervention for chronic insomnia. However, sleep-restriction components should be modified carefully in individuals with epilepsy because excessive sleep restriction may precipitate seizuresRestless legs syndrome should be evaluated and managed according to standard clinical recommendations. Iron deficiency, when present, should be identified and corrected. Suspected parasomnias should be differentiated from nocturnal seizures before treatment is initiatedOptimising antiseizure medication: Antiseizure medications (ASMs) can influence sleep architecture, alertness, and daytime functioning. Some medications may cause sedation or fatigue, whereas others may contribute to insomnia or sleep fragmentation. Polytherapy may further increase the likelihood of sleep-related adverse effectsMedication selection, dosage, and administration timing should therefore be individualised according to seizure type, epilepsy syndrome, comorbidities, and adverse-effect profiles. In selected individuals with predominantly nocturnal seizures, adjustments in medication timing may be considered by the treating neurologist. Medication changes should not be undertaken without medical supervisionPractical clinical approachClinical findingRecommended approachBreakthrough seizures associated with sleep deprivationReview sleep schedules, identify triggers, and reinforce sleep hygiene.Snoring and excessive daytime sleepinessScreen for OSA and consider polysomnography.Persistent difficulty initiating or maintaining sleepEvaluate insomnia and consider CBT-I.Daytime sedationReview ASM selection, dosage, and administration timing.Abnormal nocturnal movements or behavioursConsider video-EEG polysomnography to differentiate seizures from parasomnias.Persistent sleep fragmentationInvestigate nocturnal seizures and coexisting sleep disorders.ConclusionSleep optimisation represents an important, potentially modifiable component of comprehensive epilepsy management. Sleep deprivation, OSA, insomnia, and circadian rhythm disturbances may contribute to poor seizure control, while nocturnal seizures and ASM-related adverse effects can further compromise sleep quality. Routine screening, appropriate diagnostic investigations, consistent sleep hygiene, treatment of comorbid sleep disorders, and individualised ASM optimisation should therefore be integrated into clinical care. Although improvements in sleep quality may support better seizure outcomes, sleep-directed interventions should complement rather than replace appropriate antiseizure treatment. A multidisciplinary approach involving neurologists, sleep specialists, and primary care clinicians can help improve seizure control, cognitive functioning, daytime alertness, and overall quality of life.Reference(s):1. Nobili L, Frauscher B, Eriksson S, et al. Sleep and epilepsy: A snapshot of knowledge and future research lines. J Sleep Res. 2022;31(4):e13622. doi:10.1111/jsr.13622. https://pmc.ncbi.nlm.nih.gov/articles/PMC9540671/2. Costanza C, Siciliano M, Gallai B, et al. Epilepsy and sleep. In: Epilepsy and Sleep. IntechOpen; 2025. doi:10.5772/intechopen.1008482. https://www.intechopen.com/chapters/1193616